CASEBIA

Welcome to the Brand page for “CASEBIA”, which is offered here for Gene therapy products, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; gene therapy products, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “CASEBIA” is believed to be currently owned by “Casebia Therapeutics Limited Liability Partnership”.